Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study.
Haiyan ZhouShuhua LiHongmei YuShenggang SunXinhua WanXiaodong ZhuChun-Feng LiuLing ChenWei XiangYaqing SunHai-Bo ChenSheng-Di ChenPublished in: Parkinson's disease (2021)
In Chinese patients with advanced PD and sleep disturbances, pramipexole SR and IR have similar benefits in the treatment of nocturnal symptoms and safety, and an improvement from baseline in nocturnal symptoms was observed regardless of pramipexole formulation.